Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

octapharma (ip) ltd., - imunoglobulin anti-d, humani - raztopina za injiciranje - imunoglobulin anti-d, humani 750 i.e. / 1 ml - humani imunoglobulin anti-d (rh)

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

octapharma (ip) ltd., - imunoglobulin anti-d, humani - raztopina za injiciranje - imunoglobulin anti-d, humani 750 i.e. / 1 ml - humani imunoglobulin anti-d (rh)

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dr. falk pharma gmbh - ursodeoksiholna kislina - peroralna suspenzija - ursodeoksiholna kislina 250 mg / 5 ml - ursodeoksiholna kislina

Evropska unija - slovenščina - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orion corporation - kvetiapin - žvečljiva tableta - kvetiapin 100 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orion corporation - kvetiapin - žvečljiva tableta - kvetiapin 200 mg / 1 tableta - kvetiapin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - srebrov sulfadiazin - krema - srebrov sulfadiazin 10 mg / 1 g - srebrov sulfadiazinat

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healtcare gmbh - ha seva nymc x-181 (iz seva a/california/7/2009 (h1n1)pdm09); ha seva nymc x-223a (iz seva a/texas/50/2012, ki je podoben sevu a/victoria/361/; ha seva nymc bx-51b (iz seva b/massachusetts/2/2012) - suspenzija za injiciranje - ha seva nymc x-181 (iz seva a/california/7/2009 (h1n1)pdm09) 15 µg / 0,5 ml  ha seva nymc x-223a (iz seva a/texas/50/2012, ki je podoben sevu a/victoria/361/15 µg / 0,5 ml  ha seva nymc bx-51b (iz seva b/massachusetts/2/2012)15 µg / 0,5 ml; ha seva nymc x-223a (iz seva a/texas/50/2012, ki je podoben sevu a/victoria/361/ 15 µg / 0,5 ml  ha seva nymc bx-51b (iz seva b/massachusetts/2/2012)15 µg / 0,5 ml; ha seva nymc bx-51b (iz seva b/massachusetts/2/2012) 15 µg / 0,5 ml - cepivo proti gripi, z delci virusov ali s površinskimi antigeni, inaktivirano